Abstract Background In September 2003, the Canadian government committed to developing legislation that would facilitate greater access to affordable medicines for developing countries. Over the course of eight months, the legislation, now known as Canada's Access to Medicines Regime (CAMR), went through a controversial policy development process and the newspaper media was one of the major venues in which the policy debates took place. The purpose of this study was to examine how the media framed CAMR to determine how policy goals were conceptualized, which stakeholder interests controlled the public debate and how these variables related to the public policy process. ...
The Ministry of Health’s announcement of a National Orphan Drug Framework on 3 October 2012 was the ...
The Canadian debate over public versus private delivery and financing of healthcare has been extensi...
Background: Canadians have long been proud of their universal health insurance syst...
Abstract Background In September 2003, the Canadian g...
Decisions to reform pharmaceutical policy often involve trade-offs between competing social and comm...
Abstract Background Following the Implementation of P...
Canada is the only OECD country that provides broad public health benefits but lacks a universal, na...
Abstract Canadian reports have recommended that health as a human right must be Canada...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
This thesis explores the role of the media and communication in the politics of the HIV/AIDS pandemi...
Objectives: Understanding the information behaviour of policy makers targeted by knowledge translat...
Canada was the first country to implement the WTO Decision of August 30, 2003, authorizing the expor...
The current COVID-19 pandemic has highlighted the significance of the export-oriented compulsory lic...
Objectives and Methods: Pharmaceutical policy is an increasingly costly, essential and challengin...
Objectives: Unlike other high-income countries, Canada has no national policy for drugs treating rar...
The Ministry of Health’s announcement of a National Orphan Drug Framework on 3 October 2012 was the ...
The Canadian debate over public versus private delivery and financing of healthcare has been extensi...
Background: Canadians have long been proud of their universal health insurance syst...
Abstract Background In September 2003, the Canadian g...
Decisions to reform pharmaceutical policy often involve trade-offs between competing social and comm...
Abstract Background Following the Implementation of P...
Canada is the only OECD country that provides broad public health benefits but lacks a universal, na...
Abstract Canadian reports have recommended that health as a human right must be Canada...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
This thesis explores the role of the media and communication in the politics of the HIV/AIDS pandemi...
Objectives: Understanding the information behaviour of policy makers targeted by knowledge translat...
Canada was the first country to implement the WTO Decision of August 30, 2003, authorizing the expor...
The current COVID-19 pandemic has highlighted the significance of the export-oriented compulsory lic...
Objectives and Methods: Pharmaceutical policy is an increasingly costly, essential and challengin...
Objectives: Unlike other high-income countries, Canada has no national policy for drugs treating rar...
The Ministry of Health’s announcement of a National Orphan Drug Framework on 3 October 2012 was the ...
The Canadian debate over public versus private delivery and financing of healthcare has been extensi...
Background: Canadians have long been proud of their universal health insurance syst...